Results 11 to 20 of about 103,208 (260)

Probiotic Yeasts Inhibit Virulence of Non-albicans Candida Species

open access: yesmBio, 2019
Systemic infections of Candida species pose a significant threat to public health. Toxicity associated with current therapies and emergence of resistant strains present major therapeutic challenges.
Lohith Kunyeit   +3 more
doaj   +1 more source

Magnolol as a potent antifungal agent inhibits Candida albicans virulence factors via the PKC and Cek1 MAPK signaling pathways

open access: yesFrontiers in Cellular and Infection Microbiology, 2022
Magnolol, a lignin compound extracted from Magnolia officinalis Cortex, has been found to have prominent antifungal effects against Candida albicans. However, the specific mechanism still remains unclear.
Yufei Xie, Hong Hua, Peiru Zhou
doaj   +1 more source

Calcification by Candida albicans [PDF]

open access: yesJournal of Bacteriology, 1975
Candida albicans was grown in a chamically defined medium in which certain microorganisms are known to calcify. The fungus developed calcium phosphate deposits with the same X-ray diffraction maxima as biological apatite.
J, Ennever, F E, Summers
openaire   +2 more sources

Clinical characteristics, risk factors, and outcomes of Candida albicans bloodstream and lower respiratory tract infections [PDF]

open access: yesBIO Web of Conferences
The purpose of this study was to investigate the clinical characteristics, risk factors and prognosis of patients with Candida albicans blood flow and lower respiratory tract infection Method: The data of 164 patients with suspected Candida albicans ...
Wang Yizhi
doaj   +1 more source

LIQUID SMOKE SUBMERSIVE EFFECTIVENESS OF ACRYLIC PLATE TO THE GROWTH OF CANDIDA ALBICANS

open access: yesJurnal Kedokteran Diponegoro, 2021
Background: Acrylic denture was an alternative to replace a lost tooth, and surrounding tissues have the part of the acrylic plate, which was frequently a place of Candida albicans proliferation.
Mochamad Haldi Tri Hutama   +4 more
doaj   +1 more source

A Candida albicans PeptideAtlas [PDF]

open access: yesJournal of Proteomics, 2014
Candida albicans public proteomic datasets, though growing steadily in the last few years, still have a very limited presence in online repositories. We report here the creation of a C. albicans PeptideAtlas comprising near 22,000 distinct peptides at a 0.24% False Discovery Rate (FDR) that account for over 2500 canonical proteins at a 1.2% FDR.
Vialás, Vital   +9 more
openaire   +5 more sources

Phenotypic identification of Candida species and relative expression of candida drug resistance (CDR1) gene in fluconazole resistant and sensitive Candida albicans

open access: yesJournal of University Medical & Dental College, 2023
: Background and objective: Candida albicans belongs to the genus Candida. It is a commensal yeast in healthy individuals and can cause wide variety of infections in immune-compromised patients.
Muneeza Muneeza Umer
doaj   +1 more source

Non-albicans Candida Infection: An Emerging Threat

open access: yesInterdisciplinary Perspectives on Infectious Diseases, 2014
The very nature of infectious diseases has undergone profound changes in the past few decades. Fungi once considered as nonpathogenic or less virulent are now recognized as a primary cause of morbidity and mortality in immunocompromised and severely ill ...
Sachin C. Deorukhkar   +2 more
doaj   +1 more source

Serotypes of Candida albicans [PDF]

open access: yesNature, 1965
THE classification of Candida albicans into two serological groups on the basis of agglutination tests was first reported by Hasenclever and Mitchell1, and both in the original and subsequent papers2–4 these authors and their colleagues referred to group A and group B strains.
openaire   +2 more sources

Synergistic potential of teriflunomide with fluconazole against resistant Candida albicans in vitro and in vivo

open access: yesFrontiers in Cellular and Infection Microbiology, 2023
IntroductionCandida albicans is the primary cause of systemic candidiasis, which is involved in high morbidity and mortality. Drug resistance exacerbates these problems. In addition, there are limited antifungal drugs available.
Xiuyun Li   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy